– USA, TN – Clover Health Investments, Corp. (NASDAQ: CLOV), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, announced the appointment of Tom Tran to its Board of Directors
Tom Tran will also join the Audit Committee.
About Thomas L. Tran
Tom Tran has over 35 years of financial leadership experience in the healthcare industry and has previously held leadership roles at various prominent managed care companies. Most recently, from February 2022 to June 2023, Mr. Tran served as CFO and as a director of Upstream Care, a value-based physician enablement innovator focused on the Medicare population. From June 2018 to May 2021, he served as CFO of Molina Healthcare, Inc.
“Having dedicated my career to improving healthcare through better financial and operational strategies, I find Clover Health’s mission very compelling. I believe Clover’s innovative use of technology to drive better health outcomes represents the future of Medicare. I am excited to join the Board and help shape this vision, ensuring Clover continues to lead in value-based care,” said Tom Tran.
Tom Tran earned his Bachelor’s degree from Seton Hall University and his Master of Business Administration degree from New York University.
About Clover Health
Clover Health is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health’s Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
For more information: https://www.cloverhealth.com/en/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.